Patents
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
03/2014
03/27/2014US20140086827 Serum S100B And Uses Thereof
03/26/2014EP2711705A1 Oxidized cardiolipin as a novel pro-inflammatory factor
03/26/2014EP2711704A1 Method for selecting chemotherapy for gastric cancer patient using combination drug of tegafur, gimeracil and oteracil potassium and egfr inhibitor
03/26/2014EP2711375A1 Human Antigen Binding Proteins that bind Beta-Klotho, FGF Receptors and complexes thereof
03/26/2014EP2711023A1 Osteogenesis promoter
03/26/2014EP2711022A2 Polymer microspheres as adjuvants in the production of vaccines against scuticociliate fish parasites
03/26/2014EP2711021A1 Products and methods for stimulating an immune response
03/26/2014EP2711020A1 Products and methods for stimulating an immune response
03/26/2014EP2711019A1 Phage constructs, sequences and antigenic compositions for immunocontraception of animals
03/26/2014EP2711018A1 Engineered Fc regions for site-specific conjugation
03/26/2014EP2711017A1 Immunity inducing agent
03/26/2014EP2711015A1 Immunity induction agent
03/26/2014EP2710122A1 Cell populations having immunoregulatory activity, methods for the preparation and uses thereof
03/26/2014EP2710116A2 Avirulent modified salmonella gallinarum strains and pharmaceutical composition using the same
03/26/2014EP2710042A2 Multi-specific fab fusion proteins and methods of use
03/26/2014EP2710040A1 Anti-human-her3 antibodies and uses thereof
03/26/2014EP2710039A2 Anti-cgrp compositions and use thereof
03/26/2014EP2710038A1 COMBINATIONS OF ANTI ErbB ANTIBODIES FOR THE TREATMENT OF CANCER
03/26/2014EP2710036A1 Antibodies against tropomyosin-related kinase b receptors
03/26/2014EP2710035A1 Fgfr1 agonists and methods of use
03/26/2014EP2710033A1 Human immunodeficiency virus neutralizing antibodies and methods of use thereof
03/26/2014EP2709664A1 Blockade of tl1a-dr3 interactions to ameliorate t cell mediated disease pathology and antibodies thereof
03/26/2014EP2709663A2 Use of anti-cgrp antibodies and antibody fragments to prevent or inhibit photophobia or light aversion in subjects in need thereof, especially migraine sufferers
03/26/2014EP2709662A1 Use of anti-cgrp or anti-cgrp-r antibodies or antibody fragments to treat or prevent chronic and acute forms of diarrhea
03/26/2014EP2709661A1 Therapeutic anti-igf1r combinations
03/26/2014EP2709660A1 Prion protein antibodies for the treatment of alzheimer's disease
03/26/2014EP2709659A1 Method for detecting infections
03/26/2014EP2709658A1 Vaccine against streptococcus pneumoniae
03/26/2014EP2709657A1 Thermostable vaccine compositions and methods of preparing same
03/26/2014EP2709656A1 Protein matrix vaccine compositions including polycations
03/26/2014EP2709655A1 Vaccine preparation containing trifunctional antibodies with antigen immunogenicity enhancer properties
03/26/2014EP2709651A1 Il-12 p40 monomer, monoclonal antibody against p40 homodimer and the combination of the two for autoimmune disease treatment
03/26/2014EP2709630A1 Par1 inhibitors for use in the treatment or prevention of paramyxoviridae infections
03/26/2014EP2709603A1 Modified biotin-binding protein, fusion proteins thereof and applications
03/26/2014EP2535358A9 Radioactive metal-labeled anti-cadherin antibody
03/26/2014CN1997388B Mucinous glycoprotein (MUC-1) vaccine
03/26/2014CN1938045B Use of cd40 antibody for treating autoimmune diseases, inflammatory diesease and organ transplanting rejection
03/26/2014CN103688171A Diagnosis and treatments relating to TH2 inhibition
03/26/2014CN103687945A Anti-B7-H3 antibody
03/26/2014CN103687942A Virus-like particles and process for preparing same
03/26/2014CN103687877A Variants of humanized immunomodulatory monoclonal antibodies
03/26/2014CN103687875A Compositions for preventing and/or treating an infection by an hiv-1 virus
03/26/2014CN103687621A Monoclonal antibody and antigens for diagnosing and treating lung disease and injury
03/26/2014CN103687620A Compositions for inhibiting masp-2 dependent complement acitivation
03/26/2014CN103687619A Compositions and methods for the therapy and diagnosis of influenza
03/26/2014CN103687618A Folate receptor alpha as a diagnostic and prognostic marker for folate receptor alpha-expressing cancers
03/26/2014CN103687617A Peptide carrier fusion proteins as allergy vaccines
03/26/2014CN103687616A Dosage of dnak
03/26/2014CN103687615A Canine coronavirus vaccine
03/26/2014CN103687614A Foot and mouth disease virus recombinant vaccines and uses thereof
03/26/2014CN103687613A Protein f - a novel haemophilus influenzae adhesin with laminin and vitronectin binding properties
03/26/2014CN103687612A A process for detergent-free production of outer membrane vesicles
03/26/2014CN103687611A Listeria-based adjuvants
03/26/2014CN103667351A Application of recombinant virus vaccine in galliformes poultry by adopting duck virus enteritis virus vaccine strain as vector
03/26/2014CN103667334A Brucella melitensis recombination strain M5-delta bp26-delta znuA as well as preparation method and application thereof
03/26/2014CN103667319A Human papilloma virus (HPV) resistant trivalent vaccine as well as preparation method and application thereof
03/26/2014CN103667304A Nucleic acids
03/26/2014CN103667196A Vaccine composition containing porcine circovirus-2 antigen and swine flu antigen
03/26/2014CN103667176A Carassius auratus gibelio brain tissue cell line sensitive to cyprinid herpesvirus II, and establishing method and application thereof
03/26/2014CN103667145A Genetically engineered attenuated strains of edwardsiella tarda (E.tarda) and application thereof
03/26/2014CN103667127A Culture of Helicobacter in vitro
03/26/2014CN103667125A Mycoplasma bovis vaccine
03/26/2014CN103665168A Anti-cd14 antibody-fused protein
03/26/2014CN103665165A Bispecific antibody targeting human CD47-SIRP alpha signal passage and preparation method and application thereof
03/26/2014CN103665157A Anti-influenza-virus broad-spectrum-neutrality neutralizing molecule 1C4
03/26/2014CN103665156A Anti-influenza-virus broad-spectrum-neutrality neutralizing molecule 3E1
03/26/2014CN103665155A Anti-influenza-virus broad-spectrum-neutrality neutralizing molecule 1F2
03/26/2014CN103665154A Anti-influenza-virus broad-spectrum-neutrality neutralizing molecule 3C4
03/26/2014CN103665153A Anti-influenza-virus broad-spectrum-neutrality neutralizing molecule 1E1
03/26/2014CN103665152A Canine parvovirus single-domain antibody, and preparation method and application thereof
03/26/2014CN103665149A Schistosoma japonicum katsurada recombinant antigen as well as preparation method and application thereof
03/26/2014CN103656682A Anti-O-type foot-and-mouth disease polypeptide-nucleic acid double-effect virus-like particle vaccine and preparation method thereof
03/26/2014CN103656675A DNA (Deoxyribonucleic Acid) vaccine based on CyPA (Cyclophilin A) and Gag (Glycosaminoglycan)
03/26/2014CN103656661A Porcine Japanese encephalitis live vaccine heat-resistant lyophilized protective agent as well as preparation method and application thereof
03/26/2014CN103656660A Heat-resistant freeze-drying protective agent for animal live vaccine, preparation method and application thereof
03/26/2014CN103656641A Transcription mesosome Med23 subunit serving as target for preventing or treating cancer
03/26/2014CN103656639A Application of FKN (fractalkine) neutralizing antibody for preparing medicine for eliminating adverse metabolic memory of heart and kidney function damage of diabetic patient
03/26/2014CN103656638A Interleukin-1 alpha abs and methods of use
03/26/2014CN103656637A Application of anti-human glucose-6-phophate isomerase (GPI or G6PI) monoclonal antibody
03/26/2014CN103656636A Method for preparing riemerlla antipestifer capsular antigen and propolis vaccine
03/26/2014CN103656635A Preparation method of German cockroach allergen preparation
03/26/2014CN103656634A Vaccine composition resisting porcine circovirus and porcine infectious pleuropneumonia infection and preparation
03/26/2014CN103656633A Food grade lactic acid bacteria active carrier Group A rotavirus vaccine and preparation method thereof
03/26/2014CN103656632A Multivalent pneumococcal capsular polysaccharide composition as well as preparation method and application thereof
03/26/2014CN103656631A Multivalence pneumococcus capsular polysaccharide-protein conjugate composition and preparation method thereof
03/26/2014CN103655614A Application of adipose tissue progenitor cell for preventing or treating hepatitis
03/26/2014CN103169986B Mosaic type DNA (Deoxyribonucleic Acid) vaccine pVAXI-Hsp 70/CD 80 for preventing and immunologically treating tuberculosis
03/26/2014CN103145801B Anti-tumor CTL (Cytotoxic T Lymphocyte) epitope peptide from MTA1 (Tumor Metastasis Associated Antigen 1) and application thereof
03/26/2014CN103102412B Humanized anti-nasopharyngeal-cancer LMP2A extracellular region antibody Fab and application thereof
03/26/2014CN102949714B Swine Streptococcosis trivalent inactivated vaccine and preparation method thereof
03/26/2014CN102851376B SSR-labeled fingerprint of shiitake mushroom Guangxiang strain, and application thereof
03/26/2014CN102755644B Rabbit haemorrhagic disease tissue inactivated vaccine and preparation method thereof
03/26/2014CN102746377B Epitope peptide of mycobacterium trberculosis protein antigen, and its application
03/26/2014CN102676419B Salmonella typhi gene deletion strain, vaccine prepared from salmonella typhi gene deletion strain and application
03/26/2014CN102533680B Virus-like particles for pseudorabies virus and preparation method for same
03/26/2014CN102533671B Coxsackie virus A16-type virus strain and applications thereof
03/26/2014CN102443543B Anti-white-spot-syndrome-virus transgenic algae strain as well as preparation method and application thereof
03/26/2014CN102307893B Peptides for vaccine
03/26/2014CN102292107B Antagonists of IL-6 to raise albumin and/or lower CRP
03/26/2014CN102178952B Method for extracting human TIG (Tetanus Immune Globulin) based on chromatography
1 ... 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 ... 1823